Not provided
Not provided
Not provided
Not provided
Not provided
Study withdrawn prior to initiation
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of this study is to evaluate the differences in clinical outcomes between the Optetrak® Posterior Stabilized ("Optetrak® PS", Exactech, Gainesville, FL) and the Optetrak® Hi-Flex™ ("Optetrak® HF", Exactech, Gainesville, FL) knee designs.
The purpose of this study is to evaluate the differences in clinical outcomes between the Optetrak® Posterior Stabilized ("Optetrak® PS", Exactech, Gainesville, FL) and the Optetrak® Hi-Flex™ ("Optetrak® HF", Exactech, Gainesville, FL) knee designs. The null hypothesis is that there is no difference in postoperative knee flexion between the Optetrak® PS and Optetrak® HF groups.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Optetrak Posterior Stabilized TKR | Active Comparator | Subjects in this arm will receive an Optetrak Posterior Stabilized total knee system. |
|
| Optetrak Hi-Flex TKR | Active Comparator | Subjects in this arm will receive an Optetrak Hi-Flex total knee system. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Optetrak PS | Device | Optetrak Posterior Stabilized total knee replacement |
|
| Measure | Description | Time Frame |
|---|---|---|
| The primary outcome of interest is knee range of motion (ROM), specifically the degree of flexion. | Physician assess range of motion in knee joint | 2 years |
| Measure | Description | Time Frame |
|---|---|---|
| Knee Society Score (KSS) | Validated physician assessed outcome | 2 years |
| Hospital for Special Surgery (HSS) Knee Score | Validated physician assessed outcome |
Not provided
Inclusion Criteria:
Patient is indicated for total knee replacement with a posterior stabilized device.
Patient is between the ages of 50 and 80 years old
Patient has a Body Mass Index (BMI) < 35.0 using the following method (or comparable method)
• BMI = Weight (lbs.) ÷ Height (in.)2 x 703
Patient is skeletally mature.
Patient is willing to participate by complying with pre and postoperative visit requirements, over at least a 1-year period, including completion of studyrequired questionnaires.
Patient is willing and able to review and sign a study Informed Consent.
Exclusion Criteria:
Patient has a Body Mass Index (BMI) > 35.0 using the following method (or comparable method)
• BMI = Weight (lbs.) ÷ Height (in.)2 x 703
Patient is skeletally mature
Patient is willing to participate by complying with pre and postoperative visit requirements, over at least a 1-year period, including completion of study required questionnaires.
Patient is willing and able to review and sign a study Informed Consent.
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Jason Drenning, Ph.D. | Exactech | Study Director |
| John W. Aldridge, MD | Hampton Roads Orthopedics | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Hampton Roads Orthopedics | Newport News | Virginia | 23606 | United States |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Optetrak Hi-Flex | Device | Optetrak Hi-Flex total knee replacement |
|
| 2 years |
| Patient Satisfaction | Visual Analog Scale (1-10) where 10 is best. | 2 years |
| Implant survivorship | Implant survivorship | 2 years |
| Radiographic evaluation | Radiographic analysis | 2 years |
| Complications | Adverse Events | 2 years |